Potential Synergy Activity of the Novel Ceragenin, CSA-13, against Carbapenem-ResistantAcinetobacter baumanniiStrains Isolated from Bacteremia Patients

One-Year Surveillance of ESKAPE Pathogens in an Intensive Care Unit of Monterrey, Mexico

(2013) Jorge Martín Llaca-Díaz et al.   CHEMOTHERAPY

Carbapenem-resistantAcinetobacter baumannii: epidemiology, surveillance and management

(2013) Jason M Pogue et al.   Expert Review of Anti-Infective Therapy

In vitro Activities of the Novel Ceragenin CSA-13, Alone or in Combination with Colistin, Tobramycin, and Ciprofloxacin, against Pseudomonas aeruginosa Strains Isolated from Cystic Fibrosis Patients

(2012) Cagla Bozkurt-Guzel et al.   CHEMOTHERAPY

Strategies for the Discovery and Advancement of Novel Cationic Antimicrobial Peptides

(2012) E. B. Hadley et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular characterization of oxacillinases and genotyping of invasive Acinetobacter baumannii isolates using repetitive extragenic palindromic sequence-based polymerase chain reaction in Ankara between 2004 and 2010

(2012) Alper Ergin et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Colistin: new lessons on an old antibiotic

(2011) D. Yahav et al.   CLINICAL MICROBIOLOGY AND INFECTION

Depolarization, Bacterial Membrane Composition, and the Antimicrobial Action of Ceragenins

(2010) R. F. Epand et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control

(2010) Y. Carmeli et al.   CLINICAL MICROBIOLOGY AND INFECTION

Multiresistant Acinetobacter baumannii infections: epidemiology and management

(2010) José Garnacho-Montero et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Naples, Italy, Shows the Emergence of a Novel Epidemic Clone

(2010) M. Giannouli et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Anti-Trypanosomatid Activity of Ceragenins

(2010) Diana Lara et al.   JOURNAL OF PARASITOLOGY

Ceragenin CSA-13 exhibits antimicrobial activity against cariogenic and periodontopathic bacteria

(2010) E. Isogai et al.   Oral microbiology and immunology

Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice

(2009) Katarzyna Leszczyńska et al.   BMC MICROBIOLOGY

Global spread of carbapenem-resistant Acinetobacter baumannii

(2009) P. G. Higgins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ceragenins: A Class of Antiviral Compounds to Treat Orthopox Infections

(2009) Michael D. Howell et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Ceragenins: Cholic Acid-Based Mimics of Antimicrobial Peptides

(2008) Xin-Zhong Lai et al.   ACCOUNTS OF CHEMICAL RESEARCH

Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options

(2008) Lisa L. Maragakis et al.   CLINICAL INFECTIOUS DISEASES

Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens

(2008) S. Saha et al.   JOURNAL OF APPLIED MICROBIOLOGY